A DNA vaccine against Escherichia coli O157:H7

Iranian Biomedical Journal

Volumn 16, Issue 3, 2012, Pages 133-139

  Mehr, Kowsar Shariati ^a   Mousavi, Seyed Latif ^a   Rasooli, Iraj ^a   Amani, Jafar ^b   Rajabi, Masoumeh ^c  

^a SHAHED UNIVERSITY   (Iran)

^b BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

DNA vaccines; Escherichia coli O157:H7; Virulence factors

Indexed keywords

BACTERIAL PROTEIN; DNA VACCINE; ESCHERICHIA COLI SECRETED PROTEIN A; FREUND ADJUVANT; GREEN FLUORESCENT PROTEIN; IMMUNOGLOBULIN G ANTIBODY; INTIMIN; INTIMIN RECEPTOR; PARVOVIRUS VECTOR; PLASMID VECTOR; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BACTERIAL VIRULENCE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DRUG DESIGN; DRUG MIXTURE; DRUG SYNTHESIS; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; ESCHERICHIA COLI O157; EXPERIMENTAL MOUSE; FEMALE; GENE CONSTRUCT; GENE FUNCTION; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; MOLECULAR CLONING; MOUSE; NONHUMAN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROVOCATION TEST; RESIDUE ANALYSIS; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; ANTIBODY SPECIFICITY; BACTERIAL SHEDDING; BASE SEQUENCE; CLONING, MOLECULAR; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; FEMALE; GENES, SYNTHETIC; GREEN FLUORESCENT PROTEINS; HEK293 CELLS; HUMANS; IMMUNIZATION; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; MICROSCOPY, FLUORESCENCE; MOLECULAR SEQUENCE DATA; VACCINES, DNA;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; EUKARYOTA; MUS;

EID: 84871837242     PISSN: 1028852X     EISSN: None     Source Type: Journal    
DOI: 10.6091/ibj.1059.2012     Document Type: Article

References (25)

1. Girard MP, Steele D, Chaignat CL, Kieny MP. A review of vaccine research and development: human enteric infections. Vaccine. 2006 Apr.24(15):2732-50.
2. Amani J, Mousavi SL, Rafati S, Salmanian AH. Immunogenicity of a plant-derived edible chimeric EspA, Intimin and Tir of Escherichia coli O157:H7 in mice. Plant Sci. 2011 Apr;180(4):620-7.
3. Moxley RA. Escherichia coli 0157:H7: an update on intestinal colonization and virulence mechanisms. Anim Health Res Rev. 2004 Jun;5(1):15-33.
4. Amani J, Salmanian AH, Rafati S, Mousavi SL. Immunogenic properties of chimeric protein from espA, eae and tir genes of Escherichia coli O157:H7. Vaccine. 2010 Oct;28(42):6923-9.
5. Clarke SC, Haigh RD, Freestone PP, Williams PH. Virulence of enteropathogenic Escherichia coli, a global pathogen. Clin Microbiol Rev. 2003 Jul;16(3):365-78.
6. Elliott SJ, Wainwright LA, McDaniel TK, Jarvis KG, Deng YK, Lai LC, et al. The complete sequence of the locus of enterocyte effacement (LEE) from enteropathogenic Escherichia coli E2348/69. Mol Microbiol. 1998 Apr;28(1):1-4.
7. Knutton S, Rosenshine I, Pallen MJ, Nisan I, Neves BC, Bain C, et al. A novel EspA-associated surface organelle of enteropathogenic Escherichia coli involved in protein translocation into epithelial cells. EMBO J. 1998 Apr;17(8):2166-76.
8. Caprioli A, Morabito S, Brugere H, Oswald E. Enterohaemorrhagic Escherichia coli: emerging issues on virulence and modes of transmission. Vet Res. 2005 May-Jun;36(3):289-311.
9. Amani J, Mousavi SL, Rafati S, Salmanian AH. In silico analysis of chimeric espA, eae and tir fragments of Escherichia coli O157:H7 for oral immunogenic applications. Theor Biol Med Model. 2009 Dec;6:28.
10. Fioretti D, Iurescia S, Fazio VM, Rinaldi M. DNA vaccines: developing new strategies against cancer. J Biomed Biotechnol. 2010;2010:174378.
11. Moreno S, Timó n M. DNA vaccination: an immunological perspective. Immunology 2004;23(1): 41-55.
12. Faurez F, Dory D, Le Moigne V, Gravier R, Jestin A. Biosafety of DNA vaccines: New generation of DNA vectors and current knowledge on the fate of plasmids after injection. Vaccine. 2010 May;28(23):3888-95.
13. Garmory HS, Perkins SD, Phillpotts RJ, Titball RW. DNA vaccines for biodefence. Adv Drug Deliv Rev. 2005 Jun;57(9):1343-61.
14. Armengol G, Ruiz LM, Orduz S. The injection of plasmid DNA in mouse muscle results in lifelong persistence of DNA, gene expression, and humoral response. Mol Biotechnol. 2004 Jun;27(2):109-18.
15. Garmory HS, Brown KA, Titball RW. DNA vaccines: improving expression of antigens. Genet Vaccines Ther. 2003 Sep;(1):2.
16. Fernandez-Borges N, Brun A, Whitton JL, Parra B, Diaz-San Segundo F, Salguero FJ, et al. DNA vaccination can break immunological tolerance to PrP in wild-type mice and attenuates prion disease after intracerebral challenge. J Virol. 2006 Oct;80(20):9970-6.
17. Alves AM, Lásaro MO, Almeida DF, Ferreira LC. DNA immunisation against the CFA/I fimbriae of enterotoxigenic Escherichia coli (ETEC). Vaccine. 2000 Nov;19(7-8):788-95.
18. Ruth N, Mainil J, Roupie V, Frère JM, Galleni M, Huygen K. DNA vaccination for the priming of neutralizing antibodies against non-immunogenic STa enterotoxin from enterotoxigenic Escherichia coli. Vaccine. 2005 May;23(27):3618-27.
19. Bentancor LV, Bilen M, Brando RJ, Ramos MV, Ferreira LC, Ghiringhelli PD et al. A DNA vaccine encoding the enterohemorragic Escherichia coli Shigalike toxin 2 A2 and B subunits confers protective immunity to Shiga toxin challenge in the murine model. Clin Vaccine Immunol. 2009 May;16(5):712-8.
20. Bouzari S, Dashti A, Jafari A, Oloomi M. Immune response against adhesins of enteroaggregative Escherichia coli immunized by three different vaccination strategies (DNA/DNA, Protein/Protein, and DNA/Protein) in mice. Comp Immunol Microbiol Infect Dis. 2010 May;33(3):215-25.
21. Sambrook J, Russell DW. Molecular cloning: a laboratory manual: Cold spring harbor laboratory press, USA, 2001.
22. Ranasinghe C, Ramshaw IA. Genetic heterologous prime-boost vaccination strategies for improved systemic and mucosal immunity. Expert Rev Vaccines. 2009 Sep;8(9):1171-81.
23. Pearson H. The dark side of E. coli. Nature. 2007 Jan;445(7123):8-9.
24. Zelenay S, Elias F, Flo J. Immunostimulatory effects of plasmid DNA and synthetic oligodeoxynucleotides. Eur J Immunol. 2003 May;33(5):1382-92.
25. Huang CF, Monie A, Weng WH, Wu TC. DNA vaccines for cervical cancer. Am J Transl Res. 2010;2(1):75-87.